Surgery for gastric cancer: 10-Year experience worldwide

被引：48

作者：

Adachi Y. ^{[1
]}

Kitano S. ^{[1
]}

Sugimachi K. ^{[2
]}

机构：

[1] First Department of Surgery, Oita Medical University, Hasama-machi, Oita 879-5593

[2] Second Department of Surgery, Kyushu University, Fukuoka

来源：

Gastric Cancer | 2001年 / 4卷 / 4期

关键词：

Cancer; Gastric cancer; Lymph node dissection; Lymph node metastasis; Quality of life; Surgery;

D O I：

10.1007/s10120-001-8007-7

中图分类号：

学科分类号：

摘要：

To demonstrate recent experience of gastric cancer surgery worldwide and to evaluate modern strategies for the treatment of gastric cancer, we investigated the English-language literature of the past 10 years, based on papers published in well-known medical journals. In many countries, the increased detection of early gastric cancer, advanced operative procedures, and careful postoperative management have improved the surgical results of gastric cancer over the years. Although randomized controlled trials in Europe showed no survival benefit of D2 resection over D1 resection, the results must be interpreted with caution and cannot be extrapolated to Japanese patients, because the morbidity and mortality after D2 gastrectomy in Japan are much less than those after D1 gastrectomy in Europe. Recently, less invasive treatments, including endoscopic mucosal resection and laparoscopic gastrectomy, have become feasible for patients with early gastric cancer, but their risks and benefits compared with traditional gastrectomy are unclear.

引用

页码：166 / 174

页数：8

共 107 条

[1]

Macintyre I.M.C., Akoh J.A., Improving survival in gastric cancer: Review of operative mortality in English language publications from 1970, Br J Surg, 78, pp. 773-778, (1991)

[2]

Akoh J.A., Sedgwick D.M., Macintyre I.M.C., Improving results in the treatment of gastric cancer: An 11-year audit, Br J Surg, 78, pp. 349-351, (1991)

[3]

Sue-Ling H.M., Johnston D., Martin I.G., Dixon M.F., Lansdown M.R.J., McMahon M.J., Et al., Gastric cancer: A curable disease in Britain, BMJ, 307, pp. 591-596, (1993)

[4]

Hansson L.E., Sparen P., Nyren O., Survival in stomach cancer is improving: Results of a nationwide population-based Swedish study, Ann Surg, 230, pp. 162-169, (1999)

[5]

Borch K., Jonsson B., Tarpila E., Franzen T., Berglund J., Kullman E., Et al., Changing pattern of histologic type, location, stage and outcome of surgical treatment of gastric carcinoma, Br J Surg, 87, pp. 618-629, (2000)

[6]

Msika S., Tazi M.A., Benhamiche A.M., Couillault C., Harb M., Faivre J., Population-based study of diagnosis, treatment and prognosis of gastric cancer, Br J Surg, 84, pp. 1474-1478, (1997)

[7]

Yildirim E., Celen O., Berberoglu U., The Turkish experience with curative gastrectomies for gastric carcinoma: Is D2 dissection worthwhile?, J Am Coll Surg, 192, pp. 25-37, (2001)

[8]

Wanebo H.J., Kennedy B.J., Chmiel J., Steele Jr. G., Wincester D., Osteen R., Cancer of the stomach: A patient care study by the American College of Surgeons, Ann Surg, 218, pp. 583-592, (1993)

[9]

Thompson G.B., Van Heerden J.A., Sarr M.G., Adenocarcinoma of the stomach: Are we making progress?, Lancet, 342, pp. 713-718, (1993)

[10]

Bonenkamp J.J., Songun I., Hermans J., Sasako M., Welvaart K., Plukker J.T.M., Et al., Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients, Lancet, 345, pp. 745-748, (1995)

← 1 2 3 4 5 6 7 8 9 10 →